Penumbra Liabilities And Stockholders Equity from 2010 to 2024

PEN Stock  USD 244.12  0.03  0.01%   
Penumbra Liabilities And Stockholders Equity yearly trend continues to be very stable with very little volatility. Liabilities And Stockholders Equity is likely to grow to about 1.6 B this year. Liabilities And Stockholders Equity is the total of all liabilities and equity in the company, which should equal Penumbra's total assets according to the accounting equation. View All Fundamentals
 
Liabilities And Stockholders Equity  
First Reported
2014-12-31
Previous Quarter
1.5 B
Current Value
1.5 B
Quarterly Volatility
473.8 M
 
Yuan Drop
 
Covid
Check Penumbra financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Penumbra's main balance sheet or income statement drivers, such as Interest Expense of 1.7 M, Total Revenue of 1.1 B or Gross Profit of 716.8 M, as well as many indicators such as Price To Sales Ratio of 7.88, Dividend Yield of 0.0 or PTB Ratio of 8.6. Penumbra financial statements analysis is a perfect complement when working with Penumbra Valuation or Volatility modules.
  
Check out the analysis of Penumbra Correlation against competitors.
To learn how to invest in Penumbra Stock, please use our How to Invest in Penumbra guide.

Latest Penumbra's Liabilities And Stockholders Equity Growth Pattern

Below is the plot of the Liabilities And Stockholders Equity of Penumbra over the last few years. It is the total of all liabilities and equity in the company, which should equal the company's total assets according to the accounting equation. Penumbra's Liabilities And Stockholders Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Penumbra's overall financial position and show how it may be relating to other accounts over time.
Liabilities And Stockholders Equity10 Years Trend
Slightly volatile
   Liabilities And Stockholders Equity   
       Timeline  

Penumbra Liabilities And Stockholders Equity Regression Statistics

Arithmetic Mean617,612,617
Geometric Mean350,437,319
Coefficient Of Variation92.92
Mean Deviation478,502,607
Median476,667,000
Standard Deviation573,898,047
Sample Variance329359T
Range1.6B
R-Value0.95
Mean Square Error34143.4T
R-Squared0.90
Slope121,994,756
Total Sum of Squares4611025.6T

Penumbra Liabilities And Stockholders Equity History

20241.6 B
20231.6 B
20221.4 B
20211.2 B
2020823 M
2019665.9 M
2018515 M

About Penumbra Financial Statements

Penumbra investors utilize fundamental indicators, such as Liabilities And Stockholders Equity, to predict how Penumbra Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Liabilities And Stockholders Equity1.6 B1.6 B

Pair Trading with Penumbra

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Penumbra position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Penumbra will appreciate offsetting losses from the drop in the long position's value.

Moving together with Penumbra Stock

  0.74GH Guardant HealthPairCorr
  0.82LH LaboratoryPairCorr

Moving against Penumbra Stock

  0.92EKSO Ekso Bionics HoldingsPairCorr
  0.72VERO Venus ConceptPairCorr
  0.59CI Cigna CorpPairCorr
  0.53DRIO DarioHealth CorpPairCorr
The ability to find closely correlated positions to Penumbra could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Penumbra when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Penumbra - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Penumbra to buy it.
The correlation of Penumbra is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Penumbra moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Penumbra moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Penumbra can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Penumbra offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Penumbra's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Penumbra Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Penumbra Stock:
Check out the analysis of Penumbra Correlation against competitors.
To learn how to invest in Penumbra Stock, please use our How to Invest in Penumbra guide.
You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Penumbra. If investors know Penumbra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Penumbra listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
2.261
Earnings Share
0.88
Revenue Per Share
30.081
Quarterly Revenue Growth
0.111
Return On Assets
0.0333
The market value of Penumbra is measured differently than its book value, which is the value of Penumbra that is recorded on the company's balance sheet. Investors also form their own opinion of Penumbra's value that differs from its market value or its book value, called intrinsic value, which is Penumbra's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Penumbra's market value can be influenced by many factors that don't directly affect Penumbra's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Penumbra's value and its price as these two are different measures arrived at by different means. Investors typically determine if Penumbra is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Penumbra's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.